Drug Channels

OCTOBER 27, 2021

Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Brrr.did you hear that? It’s the biosimilar boom! Believe it or not, U.S You can also find my daily posts on LinkedIn , where I have more than 20,000 followers.

Biosimilars 75

Biosimilars Hospitals Independent Pharmacies Pharmacy 75

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. Novartis Pharmaceuticals v.

Pharmacy 59

Pharmacy Pharmaceuticals Drugs Government 59

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. I shared my $0.02 How could I not? Click here to read the Drug Channels Institute letter to Senators Thune, Stabenow, Moore Capito, Baldwin, Moran, and Cardin. d/b/a Drug Channels Institute.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

In Australia, both methadone and buprenorphine have been subsidised by the Pharmaceutical Benefit Scheme (PBS) for the treatment of opioid dependence (termed ‘opioid agonist treatment’ or OAT) for several decades. The use of opioid agonist treatment increased in non-community pharmacy settings from early 2020.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. contains new data on hospital acquisitions and consolidation activity. Section 6.1.6.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

OCTOBER 9, 2024

distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. Read on for five key pricing, pharmacy, provider, and manufacturer trends that are driving the U.S. drug wholesaling industry.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. So, you can find out what your customers, partners, and competitors are reading.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

SEPTEMBER 2, 2020

This week, I’m rerunning some popular posts while I work on the forthcoming 2020-21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. per 3 mL pen or $0.10 per 10 mL vial.

Pharmacy 52

Pharmacy Government Hospitals Pharmaceuticals 52

Drug Channels

OCTOBER 25, 2021

Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This chart complements Follow the Dollar: The U.S. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Pharmaceuticals Hospitals 97

Drug Channels

APRIL 21, 2022

Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This chart complements Follow the Dollar: The U.S. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

SEPTEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Time for our annual update on the channels for provider-administered drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

DECEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

NOVEMBER 4, 2020

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. For your reference, I also include links to published comments from the American Hospital Association and the Pharmaceutical Research and Manufacturers of America. I shared my $0.02

Pharmacy 52

Pharmacy Hospitals Pharmaceuticals Marketing 52

The Pharma Data

NOVEMBER 5, 2020

Regeneron announced today an update from the independent data monitoring committee (DMC) for the United Kingdom-based RECOVERY trial evaluating REGN-COV2 in hospitalized patients with COVID-19.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

Advarra

MARCH 6, 2025

Over the years, Advarra has reviewed a wide range of clinical research studies and worked every day alongside leading pharmaceutical manufacturers, medical researchers, and healthcare institutions. Without clinical research, these medical breakthroughs would remain out of reach for patients.

Clinical Research 52

Clinical Research Research Clinical Trials Bioethics 52

The Pharma Data

DECEMBER 17, 2020

With years of pharmaceutical expertise to her credit, Dr. Johnson first garnered inspiration for her professional future during her formative years. Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. About Marquis Who’s Who® Since 1899, when A.

Pharmacy 52

Pharmacy Doctors Hospitals DNA 52

The Pharma Data

DECEMBER 17, 2020

17, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. NASDAQ: REGN ) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19. TARRYTOWN, N.Y. ,

Hospitals 52

Hospitals Production Clinical Trials Virus 52

Drug Channels

SEPTEMBER 11, 2024

For 2024, payers report that specialty pharmacies—via white and clear bagging—have displaced buy-and-bill for a meaningful share of commercial covered lives utilizing provider-administered oncology drugs. Below, I review the latest data on 2024 trends and compare them to the pre-pandemic figures. drug channels.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

MARCH 26, 2021

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. For your reference, I also include links to published comments from the American Hospital Association and the Pharmaceutical Research and Manufacturers of America. I shared my $0.02

Pharmacy 52

Pharmacy Hospitals Pharmaceuticals Drugs 52

The Pharma Data

OCTOBER 30, 2020

Regeneron Pharmaceuticals, Inc. NASDAQ: REGN) received today a recommendation from the independent data monitoring committee (IDMC) for the REGN-COV2 antibody cocktail treatment trials for COVID-19 that the current hospitalized patient trial be modified. About the REGN-COV2 Trial in Hospitalized Patients. TARRYTOWN, N.Y. ,

Hospitals 52

Hospitals Virus Production Clinical Trials 52

H1 Blog

JULY 24, 2023

Among the pharmacy and therapeutics (P&T) committee members DRG surveyed, 44% would use pharma digital resources more frequently if companies made it easier to find content dedicated to formulary decision-makers. P&T committees at hospitals, government organizations and insurers decide which drugs will make their formulary lists.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Treatment Pharmacy 52

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 40

The Pharma Data

OCTOBER 29, 2020

In fact, these patients are prescribed twice as many drugs as needed and are nearly twice as likely to be hospitalized or wind up in the emergency department. THURSDAY, Oct. 29, 2020 – More than one-third of older Americans are prescribed drugs they may not need, a new study finds. “As the age of the U.S. “As the age of the U.S.

Doctors 52

Doctors Drugs Pharmacy Treatment 52

Drug Target Review

AUGUST 16, 2024

I joined the pharmaceutical industry to leverage my passion and hands-on clinical experience to care for people all over the world by bringing a unique perspective to drug and device research and development. I graduated with my BS in physiology and later attended the University of Michigan Medical School.

Medical Schools 111

Medical Schools Nurses Research Production 111

The Pharma Data

NOVEMBER 16, 2020

“We believe that our investments in mRNA delivery technology and manufacturing process development will allow us to store and ship our COVID-19 vaccine candidate at temperatures commonly found in readily available pharmaceutical freezers and refrigerators,” said Juan Andres, Chief Technical Operations and Quality Officer at Moderna. “We

Vaccine 52

Vaccine FDA Clinical Trials Pharmacy 52

The Pharma Data

OCTOBER 29, 2020

In fact, these patients are prescribed twice as many drugs as needed and are nearly twice as likely to be hospitalized or wind up in the emergency department. THURSDAY, Oct. 29, 2020 – More than one-third of older Americans are prescribed drugs they may not need, a new study finds. “As the age of the U.S. “As the age of the U.S.

Doctors 40

Doctors Drugs Pharmacy Treatment 40

The Pharma Data

JANUARY 12, 2021

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations. NEW YORK–( BUSINESS WIRE )– Massive Bio, Inc. , 75N91020C00016.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

The Pharma Data

OCTOBER 28, 2020

Regeneron Pharmaceuticals, Inc. REGN-COV2 significantly reduced viral load and patient medical visits (hospitalizations, emergency room, urgent care visits and/or physician office/telemedicine visits). The Phase 3 portion of this trial continues in non-hospitalized patients.

Virus 40

Virus Trials Clinical Trials Production 40

The Pharma Data

JANUARY 3, 2021

The equipment can also effectively meet the cryogenic storage requirements of various biological samples by most drug distribution companies, hospitals, pharmacies, disease control centers, testing centers, biopharmaceutical companies, scientific research institutes and other institutions.

Vaccine 40

Vaccine Marketing Engineering Production 40

DrugBank

NOVEMBER 7, 2023

DrugBank’s customer base, which includes 13 of the top 20 pharmaceutical companies and users in more than 24 countries, have also gained access to ASHP’s evidence-based information. DrugBank is honoured to partner with the world’s leading biomedical researchers as they pursue their goal of better medical outcomes.

Pharmacy 105

Pharmacy Community Pharmacies Pharmaceutical Companies Packaging 105

The Pharma Data

DECEMBER 29, 2020

29, 2020 /PRNewswire/ — Phase 3 program in hospitalized patients to continue based on passing futility analysis on ability to reduce incidence of death or mechanical ventilation. First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19. Regeneron Pharmaceuticals, Inc.

Hospitals 52

Hospitals Trials Clinical Trials Production 52

The Pharma Data

JANUARY 12, 2021

Doses are being supplied for use pursuant to the FDA Emergency Use Authorization for high-risk patients with mild to moderate COVID-19 in order to reduce the risk of progression to severe COVID-19 and/or hospitalization. Regeneron Pharmaceuticals, Inc. NASDAQ: REGN ) today announced that the U.S. Yancopoulos , M.D., In the U.S.

Government 52

Government Hospitals Virus Clinical Trials 52

The Pharma Data

NOVEMBER 8, 2020

PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. At some hospitals, it can take up to 30 minutes to get a status epilepticus drug from the pharmacy to the point of care in the ER to treat a patient. About Sedor Pharmaceuticals, LLC. About Sesquient.

FDA Approval 52

FDA Approval FDA Treatment Long-Term Care Facilities 52

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. and Section 6.4.3.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

The Pharma Data

NOVEMBER 20, 2020

November 21, 2020 – Regeneron Pharmaceuticals, Inc. Data from approximately 800 non-hospitalized patients showed significant reductions in virus levels within days of receiving the combination, which were associated with significantly fewer medical visits. TARRYTOWN, N.Y., Food and Drug Administration (FDA). Yancopoulos, M.D.,

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

MAY 7, 2021

Covid Testing Has Turned Into a Financial Windfall for Hospitals and Other Providers ( KHN ). Goldman Sachs jumps aboard Bain-backed 503(b) compounding pharmacy with a $275M debt loan to supply hospitals ( Endpoints ). Quest Pharmaceuticals Loses In Opioid Liability Coverage Suit ( Law360 ).

Vaccine 52

Vaccine Compounding Pharmacies Regulations Drugs 52

Drug Channels

OCTOBER 19, 2020

Channel Strategy for First Medical Product – A Look at Channel Considerations for Pharmacy vs. Medical Plus – Tailored Track Options Based on Company Size : Emerging/Small Companies – Infrastructure Set-Up, License Procurement and 3PL Contracting Mid-Large Companies – How Do I Think About My Portfolio Differently Based on Product Type?

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Licensing 52